Both stocks run through our valuation models. Here is how InBody Co.Ltd (041830) and i-SENS (099190) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees InBody Co.Ltd as the less overvalued of the two: InBody Co.Ltd trades at KRW 70,000 versus a fair value of KRW 49,984 (-29%), while i-SENS trades at KRW 18,870 versus KRW 8,168 (-57%).
InBody Co.Ltd
041830.KQ · KRW · Health Care
-29%
upside to fair value
overvalued
PriceKRW 70,000
Fair ValueKRW 49,984
Quality71/100
i-SENS
099190.KQ · KRW · Health Care
-57%
upside to fair value
overvalued
PriceKRW 18,870
Fair ValueKRW 8,168
Quality49/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
InBody Co.Ltdi-SENS
Valuation
1.8%Dividend yield0.5%
Profitability
24%Net margin8%
24%Operating margin10%
—Return on equity35%
11%Return on assets4%
Growth
18%Revenue growth (YoY)16%
13.5%Avg. growth/yr (3Y)6.0%
16.9%Avg. growth/yr (5Y)9.1%
Balance & size
0.01×Debt / equity0.20×
$506MMarket cap$311M
healthyGrowth qualityexpensive
InBody Co.Ltd leads: 8 to 0 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
InBody Co.Ltdof which business quality 68 · market factors 83i-SENSof which business quality 44 · market factors 42
ProfitabilityMargins and returns on capital today
59
21
Quality GrowthAre margins and returns improving?
45
56
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
51
67
Low VolatilityCalm price path (market factor)
43
56
MomentumPrice trend over the last 3–12 months (market factor)
100
36
52W MomentumDistance to the 52-week high (market factor)
100
36
Net IssuanceBuybacks instead of dilution
100
82
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
InBody Co.Ltd
DCF ModelsKRW 65,630
Earnings-BasedKRW 34,626
MultiplesKRW 44,543
Asset-BasedKRW 15,795
Growth DCFKRW 59,979
Economic ProfitKRW 32,522
Growth EarningsKRW 53,096
21 of 24 models see the stock below the current price.
i-SENS
Earnings-BasedKRW 1,083
MultiplesKRW 4,262
Asset-BasedKRW 7,657
Economic ProfitKRW 1,083
6 of 6 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
InBody Co.Ltd
Bear KRW 37,377Fair Value KRW 49,984Bull KRW 61,591
KRW 70,000 = current price (white tick)
i-SENS
Bear KRW 4,986Fair Value KRW 8,168Bull KRW 8,168
KRW 18,870 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
InBody Co.Ltd · Health Care
Quality score71 · Top 25%
Fair value upside-29% · above median
i-SENS · Health Care
Quality score49 · below median
Fair value upside-57% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees InBody Co.Ltd as the less overvalued of the two: InBody Co.Ltd trades at KRW 70,000 versus a fair value of KRW 49,984 (-29%), while i-SENS trades at KRW 18,870 versus KRW 8,168 (-57%).
InBody Co.Ltd has the higher quality score (71/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
